While mean CAPON full-length mRNA levels were increased by 24% in patients with bipolar disorder but no history of exposure to antipsychotic medication (n = 11) as compared to normal controls, this increase did not reach statistical significance (p = 0.11). The gene discussed is NOS1AP; the disease is bipolar disorder.